2-3_header

Phase 1 Unit

Phase 1 Clinical Trial Unit

Our clinical pharmacology unit is designed specifically for Phase 1 clinical trials and is uniquely positioned to meet your high-volume enrollment needs.

Cypress, CA

With 75,000 sq. ft. and 180 beds, this CPU is dedicated to early phase trials
and can provide housing for long-term, in-house trials, with services for
normal healthy volunteers, ethnobridging, and select patient population
trials.

The Phase 1 unit is uniquely positioned between the Orange County and Los Angeles areas (Los Angeles County – 9.3 MM, Orange County – 2.7 MM, Riverside/San Bernardino Counties – 3.1 MM), giving us the ability to strategically recruit from a diverse ethnic population of over 15 million people.

Many healthy volunteers are also available for recruitment from multiple universities nearby. To ensure the success of your study’s enrollment, the Phase 1 clinical trial unit’s active outreach team aids community clinical research education and augments our overall patient recruitment efforts.

Other Notable Features

  • 130+ employees trained for Emergency Response situations
  • On-site CAP and CLIA-accredited Safety Reference Laboratory capable of conducting hundreds of clinically-significant tests
  • Peripheral Blood Mononuclear Cell (PBMC) processing capabilities
  • USP 797-compliant sterile room for parenteral drug preparation
  • 850 sq. ft. smoking rooms with fully enclosed, isolated air venting systems
Key Features/Capabilities:
Special procedures performed:
  • Bronchoscopy
  • Bio-fluid collection: stool, sputum, semen, emesis, urine, CSF
  • Biopsies
  • Cystoscopy
  • Glucose monitoring
  • Holter Monitoring & Telemetry
  • Skin testing
  • Peripheral Blood Mononuclear Cell (PBMC) processing
  • Pulmonary function testing including Bronchial Challenge Testing
  • Vaginal ultrasounds and pap smears
  • Various ophthalmic tests
  • X-rays & MRIs
Studies Performed:
  • FIH
  • SAD/MAD
  • PK/PD
  • BA/BE
  • Biosimilar
  • DDI
  • Drug delivery
  • Device
  • Food Effect
  • Cardiac safety
  • TQT

Safety Reference Laboratory

WCCT’s fully-automated safety reference laboratory is housed within our Phase I clinical trial unit. This lab is capable of conducting hundreds of clinically-significant tests for chemistry, hematology, toxicology, drug monitoring, protein analysis, medical conditions, urinalysis, and more.

The laboratory is CAP and CLIA accredited since 2017.

 

Siemens Advia 1800: Chemistry Testing

 

 

 

 

 

 

1200 Colorimetric tests and 600 ISE test per hour

Assays:

  • Drug Abuse and Toxicology:
  • Specific Proteins
  • Therapeutic Drug Monitoring
  • General Chemistry
  • Validity Testing
    • Creatinine
    • Nitrite
    • Oxidant
    • pH
    • Specific Gravity
Siemens Centaur XP: Special Chemistry and Immunoassay Testing

 

 

 

 

 

 

240 Direct Chemiluminescence test per hour

Assays:

  • Allergy
  • Anemia
  • Autoimmune
  • Bone Metabolism
  • Cardiac
  • Diabetes
  •  Hepatitis
  • HIV
  • Immuno-suppresant Drugs
  • Inflammation
  • Liver Fibrosis
  • Metabolic
  • Oncology
  • Sepsis
  • Special ID
  • Reproductive Endocrinology
  • Therapeutic Drug Monitoring
  • ToRCH
  • Thyroid
Sysmex CS-2500: Hemostasis

 

 

 

 

 

 

180 tests per hour of chromogenic immunoassay, and aggregation assays

Assays:

  • PT
  • aPTT
  • Fibrogen
  • Thrombin Time
  • Batroxobin Time
  • Factor Deficiency
  • Lupus anticoagulant
  • Protein C pathway
  • Heparin
  • D-DImer
  • Von Willebrand Factor
  • Chromogenic
Clinitek Novus and Auwipro: Urinalysis

 

 

 

 

 

 

80 tests per hour

Assays:

  • Macroscopic urinalysis
  • Microscopic urinalysis
Siemens Advia 2120

 

 

 

 

 

 

120 colorimetric samples her hour

Assays:

  •  CBC results
  • Differential results
  • Platelet results
  • Reticulocyte results
  • CSF assay results
  • Parameters
  • Morphology results
  • WBC
  • RBC and PLT
Siemens Versacell X3

Fully-automated robotic sample handling system

Early Clinical Development Expertise

With over 500 Phase 1 clinical trials completed for the development of specialized therapies and medicines, WCCT has developed a comprehensive portfolio of expertise in early clinical development

clinical_trial2

Volunteer Recruitment

Volunteer recruitment is one of the leading causes of missed deadlines and failed studies. Avoid these fallbacks with a trusted team of experts utilizing data-driven solutions to meet your study enrollment goals.

ethnobridging2

Ethnobridging Studies

Gain access to one of the highest immigrant Asian-American populations in the U.S. through WCCT’s owned-and-operated Phase 1 clinical trial unit. We have managed the successful completion of multiple ethnobridging studies on time and within, or even before, the original timeline set by the sponsor.

clinical_research2

Ophthalmology Studies

WCCT Global offers an end-to-end solution for conducting Phase I-II ophthalmic clinical trials. We combine site ownership with a network of ophthalmology research centers, investigators, and KOLs to provide its partners the services necessary to accelerate the development of new treatments.

influenza2

Viral Challenge and Vaccine

WCCT is the first commercially-approved U.S. site that can drive and accelerate influenza clinical trials through strategic identification of seronegative volunteers and optimal timing of enrollment.  We offer sponsors the freedom to conduct vaccine research in a secure environment.

Submit RFI/RFP

Tell us about your study to receive a customized proposal. Simply fill out the form below and submit your RFI/RFP. Please send attachments to: mgr@WCCT.com.

WCCT News

Stay up-to-date on clinical research news and developments.

Careers

Careers that put you at the forefront of medical breakthroughs.

Blog

The blog delivers industry-related developments and announcements regarding expanded clinical services.